Diagnosis of antipsychotic-induced movement disorders are based on the patient’s clinical presentation in combination with a thorough psychiatric, medical, and medication history. Differentiating between movement disorders may be challenging, but simple frameworks (eg, acute vs tardive, hypokinetic vs hyperkinetic) can help improve recognition. Nurses play a key role in educating patients and families about antipsychotic-induced movement disorders. Central to this education is the availability of FDA-approved medications for TD that allow the patient to remain on their current antipsychotic regimen.